Cathepsin D (CTSD) is a lysosomal aspartic protease encoded by the CTSD gene located on chromosome 11q13.2. As an acidic endopeptidase, it represents one of the most abundant proteases in mammalian lysosomes and functions optimally at pH 3.5-4.0. The protein is synthesized as a preproenzyme (pro-cathepsin D) that undergoes sequential proteolytic processing to generate the mature, catalytically active enzyme consisting of a heavy chain (34 kDa) and light chain (14 kDa) connected by a peptide linker. Cathepsin D exhibits broad substrate specificity, degrading numerous proteins including collagen, hemoglobin, myelin basic protein, and various neuropeptides. Beyond its canonical role in lysosomal protein degradation, emerging evidence indicates cathepsin D possesses non-enzymatic functions through protein-protein interactions, establishing it as a multifunctional protein critical for cellular homeostasis.
Function and Biology
...
CTSD Protein - Cathepsin D
Overview
Cathepsin D (CTSD) is a lysosomal aspartic protease encoded by the CTSD gene located on chromosome 11q13.2. As an acidic endopeptidase, it represents one of the most abundant proteases in mammalian lysosomes and functions optimally at pH 3.5-4.0. The protein is synthesized as a preproenzyme (pro-cathepsin D) that undergoes sequential proteolytic processing to generate the mature, catalytically active enzyme consisting of a heavy chain (34 kDa) and light chain (14 kDa) connected by a peptide linker. Cathepsin D exhibits broad substrate specificity, degrading numerous proteins including collagen, hemoglobin, myelin basic protein, and various neuropeptides. Beyond its canonical role in lysosomal protein degradation, emerging evidence indicates cathepsin D possesses non-enzymatic functions through protein-protein interactions, establishing it as a multifunctional protein critical for cellular homeostasis.
Function and Biology
In healthy neurons, cathepsin D serves as a principal component of the autophagy-lysosome pathway (ALP), the cellular recycling system responsible for degrading intracellular proteins and organelles. Upon lysosomal fusion with autophagosomes, cathepsin D cleaves autophagosomal cargo into amino acids and smaller molecules for cellular reuse or energy production. The enzyme participates in multiple biological processes including lysosomal turnover of membrane proteins, removal of damaged mitochondria (mitophagy), and processing of amyloid precursor protein (APP). Additionally, cathepsin D regulates neuronal apoptosis through caspase activation and can be secreted by cells in both pro- and mature forms, exhibiting extracellular activities including degradation of neurotrophic factors and modulation of extracellular matrix composition. Recent studies demonstrate that cathepsin D interacts with heat shock proteins and participates in protein quality control mechanisms essential for preventing proteotoxic accumulation.
Role in Neurodegeneration
Dysregulation of cathepsin D activity is implicated in multiple neurodegenerative diseases. In Alzheimer's disease (AD), impaired cathepsin D activity correlates with accumulation of amyloid-beta (Aβ) and tau pathology; postmortem AD brains show reduced lysosomal cathepsin D levels and activity. Mutations in CTSD cause lysosomal storage disease neuronal ceroid lipofuscinosis type 10 (CLN10), characterized by progressive accumulation of lipofuscin, neurodegeneration, and premature death. In Parkinson's disease (PD), reduced cathepsin D activity impairs clearance of α-synuclein, promoting its aggregation and contributing to Lewy body formation. Similarly, inefficient cathepsin D-mediated degradation of mutant huntingtin protein may accelerate pathology in Huntington's disease. Paradoxically, excessive cathepsin D activity can trigger inappropriate cell death through hyperactivation of apoptotic cascades, suggesting a critical balance must be maintained. Age-related decline in cathepsin D activity and expression contributes to accumulation of protein aggregates observed in aging-associated neurodegeneration.
Molecular Mechanisms
Cathepsin D dysfunction in neurodegeneration involves multiple interconnected mechanisms. Impaired autophagosome-lysosome fusion reduces cathepsin D access to substrates, decreasing protein degradation efficiency. Lysosomal acidification defects prevent optimal cathepsin D catalytic activity. Proteolytic processing of pro-cathepsin D can be dysregulated, reducing mature enzyme availability. The protein interacts with acid sphingomyelinase (ASM), DJ-1, and Hsp70/90 family chaperones; disruption of these interactions compromises protein quality control. In APP metabolism, cathepsin D directly cleaves APP to generate potentially neurotoxic fragments. Pro-cathepsin D can localize to mitochondria and trigger caspase-mediated apoptosis under stress conditions. Additionally, cathepsin D regulates expression of other cathepsins and proteases through feedback mechanisms, and altered cathepsin D levels can disrupt this proteolytic balance.
Clinical and Research Significance
Cathepsin D represents both a therapeutic target and a potential biomarker for neurodegenerative diseases. Increased cerebrospinal fluid (CSF) and plasma cathepsin D levels show promise as early diagnostic markers for AD and other tauopathies. Therapeutic approaches include pharmacological enhancement of cathepsin D activity through autophagy modulators, gene therapy to restore CTSD expression in deficiency states, and monoclonal antibodies targeting pathological substrates. Understanding cathepsin D biology informs development of disease-modifying treatments for neurodegeneration.